Literature DB >> 7026550

A comparative study of high molecular weight urokinase and low molecular weight urokinase.

M Nobuhara, M Sakamaki, H Ohnishi, Y Suzuki.   

Abstract

Two forms of urokinase [EC 3.4.99.26] with molecular weights of 51,600 and 34,500 were purified from human urine. The specific activities of the high molecular weight urokinase (HMW-UK) and low molecular weight urokinase (LMW-UK) were 157,400 and 246,700 International Units (IU/mg), respectively. Purified HMW-UK was 97% active and LMW-UK was 88% active, as judged by using p-nitrophenyl-p'-guanidinobenzoate. LMW-UK had five multiple isoelectric subforms, compared with HMW-UK which had only one. Not only HMW-UK but also LMW-UK was composed of two polypeptide chains linked by disulfide bond(s). The molecular weight of the heavy chain of both forms was the same (34,000 daltons), while the molecular weight of the light chain of HMW-UK was 17,600 and that of LMW-UK was approximately 1,200-3,400. Enzyme kinetic studies revealed that the kinetic constants, Km and Kcat, of both forms toward the synthetic substrates, acetyl-Gly-Lys-methylester (AGLMe) and glutaryl-Gly-Arg-4-methylcoumarin-7-amide (GGA-MCA), were almost the same, but the dissociation constant of HMW-UK toward Glu-plasminogen was 2.4-2.6 times less than that of LMW-UK. HMW-UK incubated at 37 degrees C was converted into LMW-UK in an autocatalytic digestion manner leading to no loss of the total activity. These results show that HMW-UK with a higher affinity toward Glu-plasminogen is converted into LMW-UK with a lower affinity, a greater portion of the light chain of HMW-UK splitting off.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026550     DOI: 10.1093/oxfordjournals.jbchem.a133453

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Elastase digested urokinase (ED-UK).

Authors:  H Sumi; T Kosugi; N Toki; H Mihara
Journal:  Experientia       Date:  1985-12-15

2.  Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA.

Authors:  Nico Dreymann; Julia Wuensche; Wiebke Sabrowski; Anja Moeller; Denise Czepluch; Dana Vu Van; Susanne Fuessel; Marcus M Menger
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

Review 3.  Biophysical Mechanisms Mediating Fibrin Fiber Lysis.

Authors:  Nathan E Hudson
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.